Patent ID: 9220767
Filing Date: 2015-12-29
Classification: A61K,A61P,C12N

Abstract:
1. A method for treating or preventing influenza in an individual, the method comprising administering to the individual a prophylactically or therapeutically effective quantity of a vaccine composition, wherein the vaccine composition comprises: at least one prophylactically active agent against influenza, and at least one adjuvant, wherein the adjuvant is a derivative of a galactosylceramide, wherein the at least one prophylactically active agent against influenza is selected from the group consisting of a live attenuated influenza virus, a killed or inactivated influenza virus, a subunit of an influenza virus, a recombinant polypeptide or protein from an influenza virus, a cDNA from an influenza virus or a recombinant influenza virus, of a first strain of influenza virus; wherein the vaccine composition is effective against a second strain of influenza virus different from the first strain of influenza virus, and wherein the vaccine composition is administered intramuscularly.